Skip to content
Review Open access

PRNP D178N-129MM prion disease: Creutzfeldt-Jakob disease-like cortical ribboning without prominent early insomnia

Sep 2026 · Frontiers in Neuroscience · Vol 20 · 0 citations · 22 references
Medicine

Abstract

Background The PRNP p.Asp178Asn (D178N) mutation on a methionine-bearing codon-129 allele is classically associated with fatal familial insomnia (FFI), but some carriers develop a Creutzfeldt-Jakob disease (CJD)-like phenotype. Case presentation and findings We report a 59-year-old woman with two months of rapidly progressive cognitive-language decline, caregiver-observed nocturnal sitting-up and sleep talking, weight loss, extensive cortical diffusion-weighted imaging (DWI) ribboning, positive cerebrospinal fluid 14–3-3, and positive multisite skin real-time quaking-induced conversion. Electroencephalography showed diffuse slowing without periodic sharp-wave complexes. PRNP sequencing identified D178N with methionine homozygosity at codon 129. A focused literature review identified six previously reported individual D178N-129MM cases with prion-compatible cortical or cortical-striatal DWI abnormalities. Because these reports were selectively ascertained by imaging and used heterogeneous clinical assessments, they were not treated as a clinical series or compared numerically with MRI-negative cohorts. Other D178N-129MM reports show normal DWI in non-insomnia cognitive or motor presentations, objective sleep abnormalities preceding insomnia, and occasional cortical DWI hyperintensity in FFI cohorts. Conclusion D178N-129MM disease shows substantial phenotypic and imaging heterogeneity. Marked CJD-like cortical ribboning can occur in an initially non-sleep-dominant presentation and should not exclude an FFI-associated genotype. MRI pattern alone should not be used to infer a specific clinical phenotype; PRNP sequencing and objective sleep assessment remain important when clinically appropriate.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.